Monitoring response and resistance to the novel arsenical darinaparsin in an AML patient

Monitoring response and resistance to the novel arsenical darinaparsin in an AML patient

Acute myeloid leukemia (AML) with inversion of chromosome 3 is characterized by overexpression of EVI1 and carries a dismal prognosis. Arsenic-containing compounds have been described to be efficacious in malignancies overexpressing EVI1. Here we describe a case of AML with inv(3)(q21q26.2) treated...

Full description

Saved in:
Bibliographic Details
Main Authors: Torsten Holm eNielsen (Author), Nathalie eJohnson (Author), Nicolas eGarnier (Author), Stanley eKwan (Author), Lu eYao (Author), Eftihia eCocolakis (Author), Josée eHébert (Author), Robert A. Morgan (Author), Éric ePaquet (Author), Kevin P. Callahan (Author), Craig T. Jordan (Author), Sarit eAssouline (Author), Wilson H. Miller (Author), Koren K. Mann (Author)
Format: Book
Published: Frontiers Media S.A., 2013-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items